Astrana Health executive surrenders shares for taxes

Astrana Health, Inc. COO and CFO Basho Chandan reported a routine share surrender to cover taxes on vested equity.

Rhea-AI Filing Summary

Astrana Health, Inc. COO and CFO Basho Chandan reported a routine share surrender to cover taxes on vested equity. On May 16, 2026, he surrendered 8,155 shares of common stock at an indicated value of $38.26 per share to satisfy tax withholding obligations on restricted stock that vested that day.

After this tax-withholding disposition, Chandan directly owns 159,610 shares of Astrana Health common stock. This total includes 15,202 shares of unvested restricted stock scheduled to vest on May 16, 2027, as well as 15,604 restricted stock units vesting in four equal semi-annual installments beginning October 2, 2026 and 20,027 restricted stock units vesting in six equal semi-annual installments beginning September 5, 2026, all subject to continued employment.

Insider Trade Summary

Exercise Price or Tax Liability: 8,155 shares

Exercise Price or Tax Liability 1 txn

Insider Basho Chandan

Role COO and CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	8,155	$38.26	$312K

Holdings After Transaction: Common Stock — 159,610 shares (Direct)

Footnotes (2)

1. F1. Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026.
2. F2. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.

Key Figures

Shares surrendered for taxes: 8,155 shares Indicated value per share: $38.26 per share Shares owned after transaction: 159,610 shares +3 more

6 metrics

Shares surrendered for taxes 8,155 shares Tax-withholding disposition on May 16, 2026

Indicated value per share $38.26 per share Value used for tax-withholding surrender

Shares owned after transaction 159,610 shares Direct ownership following May 16, 2026 disposition

Unvested restricted stock 15,202 shares Scheduled to vest on May 16, 2027

RSUs vesting in four installments 15,604 RSUs Vest in four semi-annual installments from October 2, 2026

RSUs vesting in six installments 20,027 RSUs Vest in six semi-annual installments from September 5, 2026

Key Terms

restricted stock, restricted stock units, tax withholding obligations, semi-annual installments

4 terms

restricted stock financial

"Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

restricted stock units financial

"Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer)..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026."

semi-annual installments financial

"which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Astrana Health (ASTH) report for Basho Chandan?

Astrana Health reported that COO and CFO Basho Chandan surrendered 8,155 shares of common stock to cover tax withholding. The shares were valued at $38.26 each and relate to restricted stock that vested on May 16, 2026.

Was the Astrana Health (ASTH) Form 4 transaction an open-market sale?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were surrendered back to offset tax obligations triggered when restricted stock vested on May 16, 2026, a common administrative event for equity compensation.

How many Astrana Health (ASTH) shares does Basho Chandan hold after the transaction?

Following the tax-withholding disposition, Basho Chandan directly owns 159,610 shares of Astrana Health common stock. This figure includes unvested restricted stock and multiple tranches of restricted stock units that will vest over time, subject to continued employment.

What future vesting equity does Astrana Health (ASTH) disclose for Basho Chandan?

The filing notes 15,202 shares of unvested restricted stock vesting on May 16, 2027. It also lists 15,604 restricted stock units vesting in four semi-annual installments from October 2, 2026 and 20,027 restricted stock units vesting in six semi-annual installments from September 5, 2026.

What does transaction code "F" mean in the Astrana Health (ASTH) Form 4?

Transaction code "F" represents a payment of exercise price or tax liability by delivering securities. In this case, 8,155 shares were surrendered to cover tax withholding on vested restricted stock, rather than being sold in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basho Chandan

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/16/2026		F		8,155(1)	D	$38.26	159,610(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on May 16, 2026.

2. Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.

	/s/ Kathy Diep, as Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)